Abstract:Pyrimidine scaffolds are an exceptional kind of heterocyclic ring that may be used to create and develop novel anticancer drugs. As a result, the current work described the design and synthesis of novel pyrimidine derivatives (5a-j) as potent dual inhibitors of epidermal growth factor receptor (EGFR) and integrating histone deacetylase (HDAC). Using elemental analysis and spectroscopic techniques, the structure of the newly synthesized compounds was elucidated. All the compounds were tested in vitro against MCF-7, HepG2 and A549 cell lines for their antiproliferative properties. Compared to the reference medication erlotinib, compounds 5 h and 5i demonstrated remarkably improved effectiveness against MCF-7, HepG2 and A549 cell lines and better safety towards normal WI-38 cells. The EGFR and HDAC inhibitory effects of compounds 5a, 5c, 5 g, 5 h, and 5i were assessed. With IC 50 values of 8.43 and 6.91 nM, respectively, the compounds 5 h and 5i demonstrated considerable inhibition against EGFR L858R/T790M mutant kinase. Compound 5i had a strong inhibitory effect compared to reference drug Vorinostat (SAHA) against the investigated isoenzymes of HDAC1, HDAC2, HDAC4, and HDAC6 with an IC 50 values of 22.73, 20.08, 3100, and 3.71 nM, respectively. Additionally, docking studies were performed to determine the binding mode of potent compounds 5 h and 5i, towards the potential target EGFR, HDAC1 and HDAC6 proteins. Furthermore, all of these results suggested that the target compounds 5 h and 5i might be seen as viable lead candidates for the dual inhibition of both EGFR and HDAC enzymes, which would enable the identification of novel anticancer agents.

Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors

Design, Synthesis, Anti-Tumor Activity, and Molecular Modeling of Quinazoline and Pyrido[2,3-D]Pyrimidine Derivatives Targeting Epidermal Growth Factor Receptor

Discovery of 7-bromo-1,4-dihydrothieno[3’,2’:5,6]thiopyrano[4,3-c]pyrazole-3-carboxamide derivatives as the potential epidermal growth factor receptors for tyrosine kinase inhibitors

Synthesis, biological evaluation, and molecular modeling studies of acetophenones‐tethered 1,2,4‐triazoles and their oximes as epidermal growth factor receptor inhibitors

Research Progress in Quinazoline Derivatives As Multi-Target Tyrosine Kinase Inhibitors

Research Progress on Quinazoline Derivatives with Epidermal Growth Factor Receptor Inhibiting Bioactivity

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R

Discovery of N-((3r,4r)-4-Fluoro-1-(6-((3-Methoxy-1-Methyl-1h-Pyrazol-4-Yl)Amino)-9-M Ethyl-9h-Purin-2-Yl)Pyrrolidine-3-Yl)Acrylamide (Pf-06747775) Through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic Egfr Mutants with Selectivity over Wild-Type Egfr

Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-b]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors

Design, synthesis and biological evaluation of aminopyrimidine derivatives bearing a 4,5,6,7-tetrahydrothieno [3,2-c]pyridine as potent EGFR inhibitors

Design, synthesis, biological evaluation and docking study of novel quinazoline derivatives as EGFR-TK inhibitors

Discovery of 1-{(3R,4R)-3-[5-Chloro-2-(1-methyl-1H-pyrazol-4-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxymethyl]-4-methoxy-pyrrolidin-1-yl}propenone (PF-06459988), A Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants.

Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using in silico Enabled Drug Discovery Platform

Design, synthesis and evaluation of new pyrimidine derivatives as EGFRC797S tyrosine kinase inhibitors

Discovery of 5-(Methylthio)pyrimidine Derivatives As L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors.

Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations

Discovery of a Series of Novel Phenylpiperazine Derivatives As EGFR TK Inhibitors

Synthesis, biological evaluation and molecular docking studies of new pyrimidine derivatives as potent dual EGFR/HDAC inhibitors

Discovery of thiapyran-pyrimidine derivatives as potential EGFR inhibitors

Computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1 H -imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy

Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors